MSF Access Campaign

CHA

Tag: MSF Access Campaign

MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people

Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. Hyderabad, 30 October – Doctors Without Borders/Médecins Sans Frontières (MSF) joined tuberculosis (TB) activists to disrupt...

Read more

Access to medicines: MSF demands Johnson & Johnson reduce price of lifesaving TB drug

GENEVA - Doctors Without Borders/Médecins Sans Frontières (MSF) has launched a global campaign calling on pharmaceutical corporation Johnson & Johnson (J&J) to lower the price of its anti-tuberculosis medicine bedaquiline to no more than US$1 per day for people everywhere who...

Read more

MSF urges PM Modi not to make any trade commitments to US threatening access to medicines

Ahead of the Prime Minister Narendra Modi’s visit to the US to discuss a ‘trade-package’ with the US President Donald Trump, Médecins Sans Frontières/ Doctors Without Borders (MSF) urges the Indian government to not make any commitments regarding intellectual property,...

Read more

MSF: U.S. Special 301 report undermines efforts to lower medicine prices globally

On the eve of World Intellectual Property Day, the United States Trade Representative released its annual “Special 301 Report.” Developing countries like India and Malaysia once again face unfair pressure from the US government over the measures these countries have...

Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita...

Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline....

Read more

Access to medicines

Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines. During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in...

Read more

Access Campaign

MSF in India: Projects in India Access Campaign Contact us A worldwide campaign for affordable and effective medicines In 1999, in the wake of Doctors Without Borders / Médecins Sans Frontières (MSF) being awarded the Nobel Peace Prize, MSF launched...

Read more

ASEAN and India urged not to trade away people’s lives in trade agreement

RCEP trade deal could cut medicines lifeline for people in developing countries Bangkok/Geneva - As the sixteen countries negotiating Regional Comprehensive Economic Partnership (RCEP) trade agreement meet in Bangkok this week for another round of closed-door negotiations, public health experts and...

Read more

People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India

Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes two patent oppositions filed by Delhi Network of Positive People (DNP+) before the Indian patent office, challenging additional patent claims by US pharmaceutical corporation-Gilead Sciences for the hepatitis C medicines sofosbuvir and velpatasvir....

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons